| British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis SL Mackie, C Dejaco, S Appenzeller, D Camellino, C Duftner, ... Rheumatology 59 (3), e1-e23, 2020 | 239 | 2020 |
| Neurologic involvement in scleroderma: a systematic review TN Amaral, FA Peres, AT Lapa, JF Marques-Neto, S Appenzeller Seminars in Arthritis and Rheumatism 43 (3), 335-347, 2013 | 231 | 2013 |
| An open, multi-vendor, multi-field-strength brain MR dataset and analysis of publicly available skull stripping methods agreement R Souza, O Lucena, J Garrafa, D Gobbi, M Saluzzi, S Appenzeller, ... NeuroImage 170, 482-494, 2018 | 199 | 2018 |
| Epileptic seizures in systemic lupus erythematosus S Appenzeller, F Cendes, LTL Costallat Neurology 63 (10), 1808-1812, 2004 | 196 | 2004 |
| Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy AC Coan, S Appenzeller, L Bonilha, LM Li, F Cendes Neurology 73 (11), 834-842, 2009 | 190 | 2009 |
| The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus M Postal, S Appenzeller Cytokine 56 (3), 537-543, 2011 | 187 | 2011 |
| Novos tempos, novos desafios: estratégias para equidade de acesso ao ensino remoto emergencial S Appenzeller, FH Menezes, GG Santos, RF Padilha, HS Graça, ... Revista Brasileira de Educação Médica 44, e155, 2020 | 170 | 2020 |
| Gray matter atrophy associated with duration of temporal lobe epilepsy L Bonilha, C Rorden, S Appenzeller, AC Coan, F Cendes, LM Li Neuroimage 32 (3), 1070-1079, 2006 | 156 | 2006 |
| First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano … BA Pons-Estel, E Bonfa, ER Soriano, MH Cardiel, A Izcovich, F Popoff, ... Annals of the rheumatic diseases 77 (11), 1549-1557, 2018 | 153 | 2018 |
| Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus S Appenzeller, L Bonilha, PA Rio, LM Li, LTL Costallat, F Cendes Neuroimage 34 (2), 694-701, 2007 | 147 | 2007 |
| Asymmetrical extra-hippocampal grey matter loss related to hippocampal atrophy in patients with medial temporal lobe epilepsy L Bonilha, C Rorden, JJ Halford, M Eckert, S Appenzeller, F Cendes, ... Journal of Neurology, Neurosurgery & Psychiatry 78 (3), 286-294, 2007 | 146 | 2007 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 142 | 2023 |
| Cerebral and corpus callosum atrophy in systemic lupus erythematosus S Appenzeller, JM Rondina, LM Li, LTL Costallat, F Cendes Arthritis & Rheumatism 52 (9), 2783-2789, 2005 | 141 | 2005 |
| The importance of cytokines and autoantibodies in depression M Postal, S Appenzeller Autoimmunity reviews 14 (1), 30-35, 2015 | 139 | 2015 |
| Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors CB Zeller, S Appenzeller Current cardiology reviews 4 (2), 116-122, 2008 | 139 | 2008 |
| Cervical spine involvement in rheumatoid arthritis—a systematic review AF Joaquim, S Appenzeller Autoimmunity reviews 13 (12), 1195-1202, 2014 | 135 | 2014 |
| Type I interferon in the pathogenesis of systemic lupus erythematosus M Postal, JF Vivaldo, R Fernandez-Ruiz, JL Paredes, S Appenzeller, ... Current opinion in immunology 67, 87-94, 2020 | 133 | 2020 |
| Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients S Appenzeller, A Vasconcelos Faria, LM Li, LTL Costallat, F Cendes Annals of Neurology: Official Journal of the American Neurological …, 2008 | 133 | 2008 |
| Hippocampal atrophy in systemic lupus erythematosus S Appenzeller, AD Carnevalle, LM Li, LTL Costallat, F Cendes Annals of the rheumatic diseases 65 (12), 1585-1589, 2006 | 130 | 2006 |
| Cognitive impairment in rheumatoid arthritis. S Appenzeller, MB Bertolo, LT Costallat Methods and findings in experimental and clinical pharmacology 26 (5), 339-343, 2004 | 130 | 2004 |
